ArticlePharmaceutical medicine2020
Developing Medical Affairs Leaders Who Create the Future.
Article in Pharmaceutical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Embracing Digital as a Paradigm Shift in Medical Affairs.Pharmaceutical medicine · 2026Review
- Development of a Competency Framework for Medical Affairs Professionals in Australasia.Pharmaceutical medicine · 2026Article
- Understanding the National Healthcare Ecosystem to Position Medical Affairs as a Strategic Element: Lessons Learned from AstraZeneca Spain.Pharmaceutical medicine · 2025Article
- The Evolution of In-Field Medical Affairs: Introducing the Strategic Scientific Advisor.Pharmaceutical medicine · 2025Article
- Cultivating Excellence: Future-Proofing Medical Affairs with Tailored Talent Programs.Pharmaceutical medicine · 2024Article
- Artificial Intelligence in Medical Affairs: A New Paradigm with Novel Opportunities.Pharmaceutical medicine · 2024Review
- How Can General Managers Best Leverage Medical Affairs Now and in the Future?Pharmaceutical medicine · 2024Article
- Survey on the Situation of Medical Departments in the Pharmaceutical Industry in Spain.Pharmaceutical medicine · 2024Article
- The Value and Deliverables of Medical Affairs: Affiliate Perspectives and Future Expectations.Pharmaceutical medicine · 2023Article
- Considerations for Effective Communication of Medical Information.Pharmaceutical medicine · 2023Article
- Medical Affairs Transformation in Specialty Pharma: Next-Level Collaboration at the Core.Pharmaceutical medicine · 2022Article
- Digital Transformation in Medical Affairs Sparked by the Pandemic: Insights and Learnings from COVID-19 Era and Beyond.Pharmaceutical medicine · 2022Review
- Development of a Definition for Medical Affairs Using the Jandhyala Method for Observing Consensus Opinion Among Medical Affairs Pharmaceutical Physicians.Frontiers in pharmacology · 2022Article
- The 7+ Habits of Highly Effective Medical Directors.Pharmaceutical medicine · 2021Article
- Preparing for the Next Normal: Transformation in the Role of Medical Affairs Following the COVID-19 Pandemic.Pharmaceutical medicine · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Medical affairs has evolved over recent years from a support, to a partner, to a strategic leadership function. In the future, there will be significant changes in healthcare and pharmaceutical industries, and many of these will be due to technological advances and digitalisation. Medical affairs will be largely influenced by these developments in terms of partnerships with key stakeholders, embracing innovation and patient-centric healthcare, and demonstrating value for novel treatment options. In order to secure future success within their roles, medical affairs professionals will have to demonstrate specific capabilities founded on communications and behavioural change, business leadership acumen, knowledge acquisition and self-development, and the ability to generate real-world evidence from insights and expertise within data science and analytics. It will be our responsibility as medical affairs leaders to create this foundation for the leaders of tomorrow.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.